Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs

Today, 8:08 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)

ABBV

1 minute read

Alnylam’s Lumasiran Substantially Reduces Plasma Oxalate Levels PH1 Patients With Severe Renal Impairment

By Vandana Singh

Today, 8:08 AM

Alnylam Pharmaceuticals Inc (NASDAQ: ALNY)

ALNY

4 minute read

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay

By Shanthi Rexaline

Today, 8:08 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20)

ABCL

1 minute read

Morgan Stanley Maintains Overweight on Alnylam Pharmaceuticals, Raises Price Target to $224

By Benzinga Newsdesk

Today, 8:08 AM

Morgan Stanley analyst David Lebovitz maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Overweight and raises the price target from $205 to $224.

ALNY

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 8:08 AM

ADIL

1 minute read

FDA
News

Alnylam Announces FDA Acceptance of New Drug Application for Investigational Vutrisiran for the Treatment of the Polyneuropathy of Hereditary ATTR Amyloidosis

By Benzinga Newsdesk

Today, 8:08 AM

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company's New Drug Application (NDA) for

ALNY

4 minute read

The Daily Biotech Pulse: Gemini Sinks On Data, Amgen’s Migraine Drug Approved In Japan, Liver Congress Gets Underway

By Shanthi Rexaline

Today, 8:08 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22)

ACET

5 minute read

The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs

By Shanthi Rexaline

Today, 8:08 AM

Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.

ABBV